RGD Reference Report - High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders.

Authors: Liu, Chunxin  Zhao, Lin  Fan, Ping  Ko, Ho  Au, Cheryl  Ng, Angel  Au, Lisa  Wong, Adrian  Kermode, Allan G  Mok, Vincent  Yan, Yaping  Qiu, Wei  Lau, Alexander Y 
Citation: Liu C, etal., J Clin Neurosci. 2021 Jan;83:108-111. doi: 10.1016/j.jocn.2020.11.016. Epub 2020 Dec 13.
RGD ID: 127285024
Pubmed: PMID:33317883   (View Abstract at PubMed)
DOI: DOI:10.1016/j.jocn.2020.11.016   (Journal Full-text)


BACKGROUND: Serum neurofilament light chain (sNfL) is a promising biomarker for neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS), but there is limited validation data in specific ethnic and disease groups.
OBJECTIVE: To investigate the levels of sNfL in a cohort of Chinese patients with NMOSD and compare sNfL levels in patients with different disease courses and treatments.
METHODS: We analysed sNfL levels in 153 Chinese patients with NMOSD (n = 51) and MS (n = 102) using single-molecule array (Simoa) technology. The sNfL levels were compared with those of 71 healthy controls from two centres in southern China. For each disease, we assessed correlations between sNfL and disease phases and treatments.
RESULTS: Higher levels of sNfL were found in the patients with NMOSD [17.97 (10.55-27.94) pg/mL] and MS [15.83 (8.92-25.67) pg/mL] compared to healthy controls [10.09 (7.19-13.29) pg/mL, p < 0.001]. No significant differences were found between the AQP4-IgG-positive NMOSD group and OCB-positive MS group.
CONCLUSIONS: sNfL measured by Simoa technology is a potential candidate blood biomarker for the diagnosis and disease monitoring of NMOSD in Chinese patients, warranting further prospective and multicentre studies.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
NEFLHumanmultiple sclerosis  IEP protein:increased expression:serum (human)RGD 
NeflRatmultiple sclerosis  ISONEFL (Homo sapiens)protein:increased expression:serum (human)RGD 
NeflMousemultiple sclerosis  ISONEFL (Homo sapiens)protein:increased expression:serum (human)RGD 
NEFLHumanneuromyelitis optica  IEP protein:increased expression:serum (human)RGD 
NeflRatneuromyelitis optica  ISONEFL (Homo sapiens)protein:increased expression:serum (human)RGD 
NeflMouseneuromyelitis optica  ISONEFL (Homo sapiens)protein:increased expression:serum (human)RGD 

Objects Annotated

Genes (Rattus norvegicus)
Nefl  (neurofilament light chain)

Genes (Mus musculus)
Nefl  (neurofilament, light polypeptide)

Genes (Homo sapiens)
NEFL  (neurofilament light chain)


Additional Information